Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2003
04/17/2003US20030073215 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073214 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073213 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073212 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073211 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073210 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073208 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
04/17/2003US20030073202 Polymerase transcription accelerator for use tool in determining nucleotide sequences
04/17/2003US20030073186 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073185 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073184 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073183 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073182 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073181 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073180 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073179 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073178 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073177 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073176 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030073175 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
04/17/2003US20030073168 Polypeptide for use in the diagnosis, treatment and prevention of cardiovascular diseases
04/17/2003US20030073167 DNA encoding SNORF36 receptors
04/17/2003US20030073161 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and immunological disorders
04/17/2003US20030073153 Reagent strip for use in detection and monitoring glucose in erythrocytes
04/17/2003US20030073152 Minimum procedure system for the determination of analytes
04/17/2003US20030073151 Minimum procedure system
04/17/2003US20030073150 Composition for use as diagnostic tool in peroxidase analysis
04/17/2003US20030073149 Antibody complexes and methods for immunolabeling
04/17/2003US20030073148 Antibodies binding to human airway trypsin-like protease and methods for utilizing the same
04/17/2003US20030073147 Method and device for trichomonas detection
04/17/2003US20030073146 Methods for diagnosis of low grade astrocytoma
04/17/2003US20030073145 Analyzing proteins within a sample; generate sample, expose to laser beam, measure mass of released proteins, classify protein
04/17/2003US20030073142 Immunoglobulin E vaccines and methods of use thereof
04/17/2003US20030073141 Monoclonal antibodies against a complex of human ACT and a serine protease
04/17/2003US20030073138 Reagents and solid phase components in specific binding assays free of advanced glycosylation endproducts
04/17/2003US20030073137 Periostin-based diagnostic assays
04/17/2003US20030073133 Individualization of therapy with erectile dysfunction agents
04/17/2003US20030073132 Detecting modulators of brain membrane protein; obtain membrane protein, incubate with ligand and labeled compound, measure level of binding
04/17/2003US20030073131 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders
04/17/2003US20030073130 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders
04/17/2003US20030073129 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and nervous system disorders
04/17/2003US20030073128 Activity prediction models
04/17/2003US20030073127 Novel calcium channel drugs and uses
04/17/2003US20030073126 Detection of preferential particles in sample; obtain sample, incubate with binding agent, detect bound biopolymers
04/17/2003US20030073124 System, method, and apparatus for submitting genetic samples and receiving genetic testing results anonymously
04/17/2003US20030073123 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition
04/17/2003US20030073121 Apparatus for use in the detection of preferential nucleotide sequences in sample
04/17/2003US20030073119 Screening for melanoma in skin sample; obtain skin extract nucleotide sequences, incubate with cyclin sequence probe, determine concentration of bound probe, compare to control, evaluate for skin melanoma
04/17/2003US20030073118 MID 9002, a human sulfatase family member and uses therefor
04/17/2003US20030073117 Novel protein and gene encoding the protein
04/17/2003US20030073108 Probe composition containing a binding domain and polymer chain and methods of use
04/17/2003US20030073105 Genes expressed in colon cancer
04/17/2003US20030073104 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
04/17/2003US20030073102 Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
04/17/2003US20030073097 TRAF6-regulated IKK activators (TRIKA1 and TRIKA2) and their use as anti-inflammatory targets
04/17/2003US20030073096 Pin1 as a marker for prostate cancer
04/17/2003US20030073091 Use of generic oligonucleotide microchips to detect protein-nucleic acid interactions
04/17/2003US20030073088 Generation of gene expression map; obtain sample cells, generate expression pattern for preferential genes, monitor activities associated with pattern and compare to control, evaluate for genetic defect
04/17/2003US20030073086 Detecting preferential target in sample; provide microarray, incubate with sample, allow binding, detect signal from bound particles
04/17/2003US20030073084 ING-encoded p33ING1 protein as a mediator of p53 signaling pathway in mammalian cells
04/17/2003US20030073083 Detection of gene associate with preferential chemical senstivities or resistance; obtain sample, screen gene expression pattern, compare to control, evaluate for presence of sensitivity/resistance genes
04/17/2003US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development
04/17/2003US20030073079 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, skin and tumor disorders
04/17/2003US20030073078 Method for the recognition of translating genetic coding sequences
04/17/2003US20030073077 Nucleotide sequences for use in the diagnosis, prevention and treatment of cell proliferative, skin and tumor disorders
04/17/2003US20030073076 Analyzing modulators or treatments of fibroproliferative diseases; obtain sample, incubate with modulator, monitor marker expression, decreased expression indicate effective modulator
04/17/2003US20030073074 Kit for use in monitor and dianosing nervous sytem aberrations
04/17/2003US20030073073 Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
04/17/2003US20030073071 Solid state sensing system and method for measuring the binding or hybridization of biomolecules
04/17/2003US20030073070 Measurement of protein s activity in sample; obtain sample, monitor clotting time, compare to control, evaluate protein s activity
04/17/2003US20030073069 Designing therapeutic chemical compound; obtain therapeutic compound, analyze structure, generate model, adjust structure and monitor efficiency
04/17/2003US20030073068 Methods for application of tear-based biomarkers to ophthalmic product evaluation and clinical study management
04/17/2003US20030073067 Applying a coating solution comprising nonionic surfactant to the hydrophobic surface; drying the coated hydrophobic surface of to remove the solvent from the coating solution and thereby bind nonionic surfactant to the hydrophobic surface
04/17/2003US20030072951 Substrate for immobilizing physiological material, and method of fabricating same
04/17/2003US20030072829 Bacterial isolates from organisms that respire at least partially through their skin and biologically active extracts derived therefrom
04/17/2003US20030072812 Administering at a tumor site in a mammalian subject a pharmaceutically acceptable form of at least one iron compound or complex in a suitable carrier for therapy of breast cancer
04/17/2003US20030072769 Used in the manufacture of vaccines, therapy, prophylaxis, drug screening
04/17/2003US20030072767 Compositions and methods for WT1 specific immunotherapy
04/17/2003US20030072765 For therapy and prophylaxis of bacterial infections
04/17/2003US20030072760 Anti-estrogen and immune modulator combinations for treating breast cancer
04/17/2003US20030072758 BMPR1A involvement in juvenile polyposis
04/17/2003US20030072753 Virus-like particles for the induction of autoantibodies
04/17/2003US20030072745 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030072741 Medical devices for uses in repair of damaged tissues and therapeutic agent determinations
04/17/2003US20030072714 Microfluidized leishmania lysate and methods of making and using thereof
04/17/2003US20030072710 Individualization of therapy with antidepressants
04/17/2003US20030072680 Colorimetric absorbance measurement apparatus
04/17/2003US20030072472 Image analysis systems for grading of meat, predicting quality of meat and/or predicting meat yield of an animal carcass
04/17/2003US20030072350 Accelerated thermal stress cycle test
04/17/2003US20030072004 Interferometric oil-spill detection system
04/17/2003US20030071835 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030071834 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/17/2003US20030071637 Flexible probe for measuring moisture content in soil
04/17/2003US20030071629 Gas analyzer with real-time broadband monitoring and snapshot selective detection
04/17/2003US20030070988 High-performance liquid chromatography for determination of substance and molecular weight
04/17/2003US20030070969 Comprises light source, an optical sensor, and blood collection tube; without use of optical cuvettes, mirrors, or focusing lenses
04/17/2003US20030070943 Method and apparatus for measuring deposit forming capacity of fluids using an electrochemically controlled pH change in the fluid proximate to a piezoelectric microbalance
04/17/2003US20030070942 Device and method for determining characteristics of a biomass
04/17/2003US20030070927 A reagent for staining proteins for fluorometric analysis, contains a hydrophobic dye (8-anilinonaphthalene-1-sulfonate in dimethylsulfoxide) and a fixative containing tannic acid, sulfosalicylic acid and acetic acid to precipitate protein
04/17/2003US20030070923 High-throughput electrophysiological measurement system